Related Experiment Videos
Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse
1Neural Development Unit, Institute of Child Health, University College London, UK. dhender@ich.ucl.ac.uk
Circulation Research
|September 12, 1998
Summary
Versican, a proteoglycan, plays a dynamic role in heart development. Its expression patterns suggest involvement in chamber specification and septal growth during cardiogenesis.
Area of Science:
- Developmental Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Versican (PG-M) is a chondroitin sulfate proteoglycan associated with limited cell migration, proliferation, and differentiation.
- Understanding the role of versican in embryonic development is crucial for comprehending heart formation.
Purpose of the Study:
- To investigate the spatial and temporal expression patterns of versican during mouse heart development.
- To explore the potential roles of versican in key cardiac developmental processes.
Main Methods:
- In situ hybridization to detect versican mRNA distribution.
- Immunocytochemistry to visualize versican protein localization.
- Analysis of sectioned mouse embryos during cardiac development.
Main Results:
- Versican mRNA and protein exhibit dynamic and similar expression patterns throughout heart development.
- Expression is generalized in the tubular heart, downregulated in the atrium, and shows regional differences in the ventricle.
- Strong expression is observed in the ventricular myocardium, endocardial cushions, and developing valves.
Conclusions:
- Versican expression is dynamically regulated during heart development.
- Versican may be involved in ventricular chamber specification, septal growth and fusion, and epithelial-to-mesenchymal transformation in endocardial cushions.
- Versican is a potential key mediator in cardiogenesis, responding to endocardial-myocardial signaling.